CX-4945 is a first-in-class, orally active, potent and selective inhibitor of the protein kinase CK2, with an IC50 of 1 nM.
Product Details
| Alternative Name: | Silmitasertib, 5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid |
| |
| Formula: | C19H12ClN3O2 |
| |
| MW: | 349.8 |
| |
| CAS: | 1009820-21-6 |
| |
| Purity: | ≥95% (HPLC) |
| |
| Identity: | Determined by EM-MS, NMR |
| |
| Appearance: | Orange powder. |
| |
| Solubility: | Soluble in DMSO (16mg/ml) or ethanol (1mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
